Yes, some people do take statins once a week, and it can meaningfully lower cholesterol. This isn’t a standard first-line approach, though. Once-weekly dosing is primarily used for people who experience side effects on daily statins and would otherwise stop taking them entirely. With the right statin and dose, weekly dosing can reduce LDL cholesterol by roughly 20% to 30%, which is less than daily dosing but far better than taking nothing at all.
Why Weekly Dosing Works With Certain Statins
Not all statins are good candidates for once-a-week use. The key factor is how long the drug stays active in your body. Rosuvastatin and atorvastatin have half-lives of about 14 to 19 hours, which sounds short, but their effects on the liver’s cholesterol-producing enzyme last considerably longer than the drug itself circulates in the blood. Rosuvastatin is the most commonly used statin for intermittent dosing because of its high potency and longer duration of action. A single dose continues suppressing cholesterol production well after the drug has been cleared.
That said, a once-weekly dose doesn’t maintain the same steady suppression as a daily one. Cholesterol production ramps back up between doses. This is why the LDL reduction is smaller, and why doctors typically reserve this strategy for people who can’t tolerate daily pills rather than recommending it as a first choice.
How Much Cholesterol Reduction to Expect
The numbers depend on which statin and dose you’re taking, but the general range for intermittent dosing (including once or twice weekly) is a 20% to 40% LDL reduction. For context, daily high-intensity statins can lower LDL by 50% or more.
In one study, rosuvastatin given once a week at doses ranging from 2.5 mg to 20 mg produced significant improvements in cholesterol levels, with a mean dose of about 10 mg per week. A separate trial found that 80 mg of rosuvastatin once weekly (a dose not approved for clinical use) lowered LDL by about 29%, comparable to taking 10 mg of atorvastatin daily. A large analysis from the Cleveland Clinic found that patients on intermittent statin schedules achieved an average LDL reduction of about 21%, and 61% of them reached their target cholesterol goals. That compares favorably to patients who stopped statins altogether, where only 44% hit their goals.
Who This Approach Is Designed For
The primary reason doctors prescribe statins on a weekly schedule is muscle pain, the most common complaint that drives people to stop taking statins. Statin-associated muscle symptoms affect a significant minority of users and range from general achiness to severe weakness. For these patients, the choice often isn’t between daily and weekly dosing. It’s between weekly dosing and no statin at all.
Current clinical guidance recommends a stepwise approach when someone reports statin side effects: first, try a lower dose or switch to a different statin. If that fails, intermittent dosing with a long-acting statin like rosuvastatin or atorvastatin becomes a reasonable next step. The goal is to find the highest frequency a patient can tolerate. Some people start at once a week and gradually add additional days, potentially reaching every-other-day dosing, which provides better cholesterol control while remaining tolerable.
In one study of 50 patients who had previously experienced side effects from one or more statins, 74% tolerated once-a-week rosuvastatin successfully. And more broadly, over 90% of people with statin-related muscle symptoms can continue some form of statin therapy long-term after adjustments to the type, dose, or frequency.
What the Evidence Doesn’t Yet Show
Here’s the important caveat: while once-weekly dosing clearly lowers LDL cholesterol, there isn’t solid proof yet that it prevents heart attacks and strokes the way daily dosing does. The major clinical trials that established statins as life-saving drugs all used daily dosing. A large single-center study of statin-intolerant patients found a trend toward lower mortality with intermittent dosing compared to stopping statins entirely, but that falls short of the definitive evidence available for daily use.
This matters because LDL reduction is a strong predictor of cardiovascular benefit, but it’s a surrogate measure, not the outcome itself. Most experts believe the cholesterol lowering from intermittent dosing likely translates into some degree of heart protection, especially compared to taking nothing. But “some degree” is different from the well-quantified benefits of daily therapy.
How Weekly Dosing Typically Works in Practice
If your doctor agrees that once-weekly dosing makes sense for you, the process usually starts with one tablet per week of rosuvastatin (commonly 5 mg or 10 mg, though doses from 2.5 mg to 20 mg have been studied). After a few weeks, if you’re tolerating it well, you may be asked to add a second day per week. This gradual increase continues every one to two weeks, with the ideal outcome being daily dosing if your body cooperates. Giving patients control over their own titration schedule tends to improve both tolerance and adherence.
Your doctor will check your cholesterol levels after several weeks to see how much LDL reduction you’re actually getting. If weekly dosing alone isn’t enough, combining a low-frequency statin with a non-statin cholesterol medication is another option your doctor may consider.
One practical note: if you’re currently taking a daily statin and thinking about switching to weekly on your own, don’t. The dosing, statin choice, and monitoring involved require medical supervision. Abruptly reducing your statin frequency without guidance could leave your cholesterol poorly controlled at a time when you assumed you were still protected.